Galvanize Therapeutics Raises $100 Million to Transform Cancer Care
September 3, 2025
Galvanize Therapeutics, Inc., a medical technology company specializing in pulsed electric field (PEF) treatments for cancer and chronic lung disease, recently completed an oversubscribed $100